3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Rectal Neoplasms
5
Uterine Cervical Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Glioblastoma
3
Esophageal Neoplasms
3
Breast Neoplasms
3
Lung Neoplasms
2
Carcinoma, Hepatocellular
2
To Study Immunostatus of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Recurrence
1
Pulmonary Fibrosis
1
Prostatic Neoplasms
1
Ototoxicity
1
Neoplasms
1
MSS Metastatic Colorectal Cancer
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Ketosis
1
Insulin Resistance
1
Hearing Loss
1
Glioma
1
Germinoma
1
Esophageal Squamous Cell Carcinoma
1
Cognitive Dysfunction
1
Central Nervous System Neoplasms
1
Brain Neoplasms
1
Astrocytoma
1
Acquired Immunodeficiency Syndrome
1
Interventions
Zoledronic Acid
1
Radiotherapy
1
Preoperative Exercise
1
Observation
1
Metformin
1
Hypoglycemic Agents
1
Diet, Carbohydrate-Restricted
1
Biguanides
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Insulin Resistance
×
Radiotherapy
×
Clear all
NCT02149459
2017-10-27
SMC 0712-13
Sheba Medical Center
Phase 1
Unknown
18 enrolled